Related Experiment Videos
Potential parameters for the detection of hGH doping
A Kniess1, E Ziegler, J Kratzsch
1Institut für Dopinganalytik und Sportbiochemie, 01731, Kreischa, Germany. astrid.kniess@idas-kreischa.de
Analytical and Bioanalytical Chemistry
|May 17, 2003
Summary
Detecting human growth hormone (hGH) abuse requires a combination of serum markers, as single tests are insufficient. Mathematical analysis of markers like IGF-I and PIIINP can effectively distinguish hGH-treated athletes from placebo groups.
Area of Science:
- Endocrinology
- Sports Science
- Biochemistry
Background:
- Human growth hormone (hGH) is often misused by athletes for performance enhancement.
- Detecting hGH abuse is challenging due to the complex physiological responses and inter-individual variability.
Purpose of the Study:
- To investigate the effects of hGH administration on various serum markers in non-competitive athletes.
- To evaluate the potential of a combination of markers for detecting hGH abuse.
Main Methods:
- Fifteen non-competitive athletes received either hGH (0.06 IU/kg/day) or placebo for 14 days.
- Serum samples were collected pre-treatment, during, and up to 10 weeks post-treatment.
- Concentrations of IGF-I, IGFBP-3, ALS, PIIINP, PINP, osteocalcin, and leptin were measured.
Main Results:
- hGH rapidly increased IGF-I levels, with sustained elevation post-application.
- IGFBP-3 response was less pronounced than IGF-I, showing increases from day 4 to 15.
- PIIINP showed a delayed but prolonged increase (day 4-21), while PINP and osteocalcin had minimal response.
- Leptin levels decreased post-hGH treatment.
- A discriminant function combining markers effectively separated hGH-treated from placebo athletes without false positives.
Conclusions:
- Single serum marker determination is inadequate for detecting hGH abuse.
- A combination of markers, analyzed mathematically, can reliably differentiate hGH administration from placebo.
- The developed discriminant function offers a promising tool for anti-doping efforts.